119-S-2737 Journalist Public Summary

Headline Summary

A three-year VA pilot would offer some veterans with traumatic brain injury (TBI) or post‑traumatic stress disorder (PTSD) access to hyperbaric oxygen therapy (HBOT) through accredited community providers, funded solely by private donations and paired with an evidence update for Congress.

What It Does

In plain terms: the bill tells the Department of Veterans Affairs to test whether hyperbaric oxygen therapy—breathing pure oxygen in a pressurized chamber—helps veterans with TBI or PTSD. The VA would run the pilot in two regions, use only donated money (no taxpayer dollars), and send eligible veterans to accredited, FDA‑cleared or FDA‑supervised (investigational) treatment sites. The program ends after three years, and the Government Accountability Office (GAO) must give Congress an updated review of the research.

• Creates a VA HBOT pilot for veterans diagnosed with TBI or PTSD.
• Limits treatment sites to facilities accredited by the Joint Commission, the Undersea and Hyperbaric Medical Society, or a comparable body.
• Requires use of FDA‑approved devices or devices operating under an FDA investigational exemption.
• Sets up a dedicated VA HBOT Fund that can receive donations and be spent without fiscal‑year limits—no other funding allowed.
• Terminates the pilot and the Fund three years after enactment.
• Directs GAO to update Congress within one year on what clinical trials (VA, DoD, and private) show about HBOT for TBI/PTSD.
• Also extends an unrelated VA pension payment limit provision from 2031 to 2034.

Why It Matters

• Potential new option: Some veterans with lasting TBI/PTSD symptoms feel current treatments don’t work well enough; a structured pilot could expand options while data are gathered.
• Guardrails and cost: The pilot uses only donated funds and requires accreditation/FDA guardrails, aiming to limit risk and taxpayer exposure.
• Evidence check: The built‑in GAO review is meant to clarify mixed research findings and guide whether the VA should scale up, modify, or end HBOT access.

Who’s For It

• Sponsor: Sen. Tommy Tuberville (R‑AL), who argues veterans deserve access to additional therapies when standard treatments fall short.
• Some veterans and caregivers seeking alternatives, emphasizing personal experiences of symptom relief and the value of trying HBOT within a monitored pilot.
• Hyperbaric treatment advocates who say a VA‑run pilot with accredited sites can produce cleaner evidence and improve safety compared with ad‑hoc, out‑of‑pocket use.

Who’s Against It

• Skeptical clinicians and researchers who note that past studies on HBOT for TBI/PTSD show mixed or inconclusive results and worry resources could shift from better‑supported treatments.
• Some patient‑safety voices who caution about risks (e.g., ear/sinus injuries, oxygen toxicity) if protocols aren’t tightly controlled—even at accredited centers.
• Budget hawks who question setting up a new VA program and fund (even donation‑based) if underlying evidence remains uncertain.

What’s Next

The bill was introduced in the Senate on September 9, 2025, referred to the Veterans’ Affairs Committee, and received a committee hearing on December 10, 2025. Next steps would be a committee vote, possible full Senate consideration, House action, and then the President’s signature or veto.

Tone

Neutral, plain‑language explainer focused on what the bill does, why supporters and opponents say it matters, and where it stands in the process.